3 Growth Companies On Euronext Paris With Up To 19% Insider Ownership

As geopolitical tensions in the Middle East weigh on investor sentiment, the French market has not been immune, with the CAC 40 Index experiencing a notable decline. Despite these challenges, growth companies with high insider ownership on Euronext Paris present intriguing opportunities for investors seeking resilience and potential long-term gains.

Top 10 Growth Companies With High Insider Ownership In France

Name	Insider Ownership	Earnings Growth
Groupe OKwind Société anonyme (ENXTPA:ALOKW)	20.6%	36%
VusionGroup (ENXTPA:VU)	13.4%	81.7%
Icape Holding (ENXTPA:ALICA)	30.2%	33.9%
Arcure (ENXTPA:ALCUR)	21.4%	26.6%
La Française de l'Energie (ENXTPA:FDE)	19.9%	31.9%
S.M.A.I.O (ENXTPA:ALSMA)	17.4%	35.2%
STIF Société anonyme (ENXTPA:ALSTI)	16.4%	28.5%
Adocia (ENXTPA:ADOC)	11.9%	64%
Munic (ENXTPA:ALMUN)	27.1%	174.1%
MedinCell (ENXTPA:MEDCL)	15.8%	93.9%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Exclusive Networks (ENXTPA:EXN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exclusive Networks SA is a global cybersecurity specialist focused on digital infrastructure, with a market cap of €2.14 billion.

Operations: The company generates its revenue from three primary regions: €480 million from APAC, €4.19 billion from EMEA, and €705 million from the Americas.

Insider Ownership: 13.1%

Exclusive Networks is poised for significant earnings growth, forecasted at 33.53% annually, outpacing the French market's 12.1%. Despite a recent decline in profit margins from 5.5% to 2.7%, the company's revenue is expected to grow faster than the market average at 12.2%. A proposed acquisition by CD&R and Permira values Exclusive Networks at €2.2 billion, offering a substantial premium over its previous share price and highlighting strong insider ownership dynamics with Permira holding a significant stake.

• Dive into the specifics of Exclusive Networks here with our thorough growth forecast report.
• In light of our recent valuation report, it seems possible that Exclusive Networks is trading beyond its estimated value.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.09 billion.

Operations: The company's revenue segments include €172.65 million from the Americas and €118.54 million from the Asia-Pacific region.

Insider Ownership: 19.6%

Lectra is forecasted to achieve significant earnings growth of 29.3% annually, surpassing the French market's 12.1%. Revenue is expected to increase by 10.4% per year, outpacing the market's 5.7%. Despite this growth potential, Lectra was recently dropped from the S&P Global BMI Index and reported a decrease in net income for H1 2024 at €12.51 million compared to €14.47 million last year, with EPS declining from €0.38 to €0.33.

• Unlock comprehensive insights into our analysis of Lectra stock in this growth report.
• Our expertly prepared valuation report Lectra implies its share price may be lower than expected.

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company based in France that develops long-acting injectables across various therapeutic areas, with a market cap of €445.04 million.

Operations: The company's revenue is primarily derived from its pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 15.8%

MedinCell is poised for substantial growth, with revenue expected to rise 46.2% annually, significantly above the French market average. The company anticipates becoming profitable in three years, outpacing typical market growth rates. Recent strategic moves include a collaboration with AbbVie and governance restructuring, appointing Christophe Douat as CEO and establishing a Board of Directors. MedinCell's addition to the S&P Global BMI Index underscores its growing prominence in the pharmaceutical sector.

• Click here to discover the nuances of MedinCell with our detailed analytical future growth report.
• Insights from our recent valuation report point to the potential undervaluation of MedinCell shares in the market.

Key Takeaways

• Access the full spectrum of 21 Fast Growing Euronext Paris Companies With High Insider Ownership by clicking on this link.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com